This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Dec;6(12):1035-6.

doi: 10.1016/S1474-4422(07)70273-9. Epub 2007 Nov 7.

Preventive antimigraine therapy: the long-term outlook

James R Couch Jr

PMID: 17988948
DOI: 10.1016/S1474-4422(07)70273-9

Comment

Preventive antimigraine therapy: the long-term outlook

James R Couch Jr. Lancet Neurol. 2007 Dec.

. 2007 Dec;6(12):1035-6.

doi: 10.1016/S1474-4422(07)70273-9. Epub 2007 Nov 7.

Author

James R Couch Jr

PMID: 17988948
DOI: 10.1016/S1474-4422(07)70273-9

No abstract available

PubMed Disclaimer

Comment on

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Sánchez Del Río M, Schoenen J, Schwalen S, van Oene J; TOPMAT-MIG-303 Investigators Group. Diener HC, et al. Lancet Neurol. 2007 Dec;6(12):1054-62. doi: 10.1016/S1474-4422(07)70272-7. Epub 2007 Nov 7. Lancet Neurol. 2007. PMID: 17988947 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information